Fig. 2From: Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort studyNumber of drug resistant tuberculosis patients on second line anti-TB drugs stratified by TICs and major adverse drug events (ADEs) in Amhara Regional State Public hospitals, September 2010–December 2017Back to article page